Association of surfactant protein A polymorphisms with otitis media in infants at risk for asthma

Melinda M Pettigrew1, Janneane F Gent, Yong Zhu

  • 1Yale Center for Perinatal, Pediatric and Environmental Epidemiology, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA. melinda.pettigrew@yale.edu

BMC Medical Genetics
|August 4, 2006
PubMed

Insights

Genetic variations in surfactant protein A (SP-A) may influence the risk of otitis media in infants. Specifically, certain SP-A gene polymorphisms showed a protective effect against middle ear infections in white infants.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • Otitis media is a frequent childhood infection.
  • Surfactant protein A (SP-A) is crucial for innate immunity and infection prevention.
  • Infant susceptibility to infections is linked to early-life immune responses.

Purpose of the Study:

  • To investigate the association between SP-A gene polymorphisms and the risk of otitis media in infants.
  • To explore the role of SP-A in early-life immune defense against middle ear infections.
  • To evaluate candidate gene polymorphisms in infants at risk for asthma.

Main Methods:

  • Prospective cohort study design.
  • Candidate gene approach focusing on SP-A loci.
  • Data collection via questionnaires and quarterly infant respiratory symptom interviews.
  • Genotyping of 355 infants with complete otitis media data.

Main Results:

  • SP-A gene polymorphisms were identified at specific codons (19, 62, 133 in SP-A1; 223 in SP-A2).
  • These polymorphisms showed associations with race/ethnicity.
  • The 6A4/1A5 SP-A haplotype demonstrated a protective effect against otitis media in white infants (OR 0.23).

Conclusions:

  • SP-A gene polymorphisms may be associated with otitis media risk in white infants.
  • Further research is needed to confirm these findings across diverse ethnic groups.
  • SP-A's role in otitis media warrants continued investigation.
Abstract

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...